Citeline Podcasts
1,366 episodes - English - Latest episode: 3 days ago - ★★★★★ - 24 ratingsCiteline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Medtech Monthly: Breakthrough Device Analysis with Bradley Merrill Thompson
September 09, 2022 19:55 - 26 minutes - 10.7 MBMedtech Monthly: Breakthrough Device Analysis with Bradley Merrill Thompson by Citeline
Pink Sheet Podcast: Amylyx’s Adcom Success, Trials Leave Russia, Apolitical Drug Price Negotiations
September 09, 2022 16:54 - 42 minutes - 26.6 MBPink Sheet reporters and editors discuss the positive advisory committee recommendation for Amylyx’s proposed ALS treatment, the striking drop in clinical trials conducted in Russia following the start of the war in Ukraine, and questions about Medicare price negotiations avoiding political influence.
Getting Personal With De Oro Devices’ Sidney Collin:‘There’s A Lot Of Learning That Needs To Happen’
September 08, 2022 21:45 - 23 minutes - 13.8 MBIn this new series titled Getting Personal, we talk to new and veteran executives about the trials and tribulations in running a company while exploring their own motivations and passions. In this first edition, we talk to Sidney Collin, co-founder and CEO of De Oro Devices. Collin invented NexStride, a portable device to help overcome freezing of gait in Parkinson’s disease patients, while studying biomedical engineering at the California Polytechnic State University in 2018. Listen to the...
How Sites and Investigators Are Reflecting on Decentralized Trial Models
September 08, 2022 11:11 - 18 minutes - 10.7 MB• What are the benefits of the decentralized clinical trial (DCT) model? • What are the barriers to sites and investigators participating in DCTs? • What support measures are critical to DCT success? • What is the outlook for DCTs during the coming 3 – 5 years and how can sites and investigators contribute to their evolution? Listen to a lively discussion of these questions and more, as industry experts discuss DCT and hybrid clinical trial models. Download and listen to your free podcast fr...
Women in healthcare leadership, with Unlocking Eve
September 05, 2022 11:23 - 28 minutes - 12.5 MBWomen in healthcare leadership, with Unlocking Eve by Citeline
CEO Podcast With InnoCare CEO Jasmine Cui
September 05, 2022 11:17 - 58 minutes - 26.3 MBScrip's Brian Yang talks to Jasmine Cui, the co-founder, chairwoman and CEO of cancer and autoimmune disease-focused Chinese pharma firm InnoCare about pipeline, plans and strategy.
CEO Podcast With InnoCare CEO
September 05, 2022 11:17 - 58 minutes - 26.3 MBCEO Podcast With InnoCare CEO by Pharma Intelligence
Self-Care Regulation After COVID, With Haleon/GSCF’s Ian Urquhart
September 05, 2022 09:15 - 24 minutes - 56.4 MBIn this episode, HBW Insight talks to Haleon’s global head of regulatory intelligence and policy, Ian Urquhart, about the innovative and flexible approaches that regulators took to ensuring access to medicines during the coronavirus pandemic. Urquhart speaks about his work with the Global Self-Care Federation, where the regulatory affairs committee which he chairs has been looking into what happened during the pandemic and drawing lessons for the future. Strengthening supply chains, Rx-to-OTC...
Scrip’s Five Must-Know Things – 5 September 2022
September 05, 2022 02:54 - 17 minutes - 40.3 MBhttps://scrip.pharmaintelligence.informa.com/SC146996/Quick-Listen-Scrips-Five-MustKnow-Things
Pink Sheet Podcast: A September To Remember For US FDA, Plus New COVID-19 Boosters And Opioid Plan
September 02, 2022 19:10 - 40 minutes - 24.9 MBPink Sheet reporters and editor discuss the emergency use authorization for updated COVID-19 vaccines, the new FDA Overdose Prevention Framework, and key decisions and deadlines upcoming in September.
Cell and Gene Therapy
August 31, 2022 19:58 - 35 minutes - 22.4 MBGene, Cell, & RNA Therapy Landscape Q2 2022 - https://www.biomedtracker.com/reportdetail.cfm?reportid=1669 Gene, Cell, & RNA Therapy Landscape Q1 2022 - https://www.biomedtracker.com/reportdetail.cfm?reportid=1646 Editing The Future - https://www.biomedtracker.com/reportdetail.cfm?reportid=1608 Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3...
Day 1 Recap: American Headache Society Annual Scientific Meeting
August 29, 2022 14:27 - 12 minutes - 16.6 MBListen to highlights of the 64th Annual Scientific Meeting of the American Headache Society.
Day 2 Recap: American Headache Society Annual Scientific Meeting
August 29, 2022 14:27 - 13 minutes - 19.1 MBListen to highlights of the 64th Annual Scientific Meeting of the American Headache Society.
Day 3 Recap: American Headache Society Annual Scientific Meeting
August 29, 2022 14:27 - 12 minutes - 17.6 MBListen to highlights of the 64th Annual Scientific Meeting of the American Headache Society.
Post Conference Recap: American Headache Society Annual Scientific Meeting
August 29, 2022 14:27 - 11 minutes - 16.4 MBListen to highlights of the 64th Annual Scientific Meeting of the American Headache Society.
Scrip’s Five Must-Know Things – 29 August 2022
August 29, 2022 02:21 - 16 minutes - 37.5 MBhttps://scrip.pharmaintelligence.informa.com/SC146959/Quick-Listen-Scrips-Five-MustKnow-Things
Talking Smart Hospitals With Two Companies Working To Make Them A Reality
August 23, 2022 11:54 - 30 minutes - 13.6 MBTalking Smart Hospitals With Two Companies Working To Make Them A Reality by Citeline
Medtech Insight’s New EU Regulatory/Reimbursement Writer, Eliza Slawther, And EU Basics
August 23, 2022 11:38 - 13 minutes - 15.6 MBMedtech Insight’s New EU Regulatory/Reimbursement Writer, Eliza Slawther, And EU Basics by Citeline
Over the Counter 22 August: Psychedelic Mushrooms With Alkemist Lab CEO Elan Sudberg
August 22, 2022 09:12 - 20 minutes - 19.3 MBIn this episode, HBW Insight speaks to Elan Sudberg, CEO of Alkemist Labs and chair of the American Herbal Product Association’s Psychedelic Plants and Fungi committee. Sudberg talks about the founding of the committee and the regulatory hoops that companies will have to jump through to research and develop psychedelic supplements, as well as the benefits that psychedelic plants are thought to have on human health.
Pink Sheet Podcast: Data Protection, Price Negotiation Enacted, Warning Letters, Amylyx At ICER
August 19, 2022 15:48 - 6 minutes - 4.33 MBPink Sheet reporter reviews recent stories on US FDA concerns about the EU data protection regulation, the US enacting the Medicare price negotiation law, warning letters sent to Emergent BioSolutions and ImprimisRx, and Amylyx’s ALS drug going in front of the Institute for Clinical and Economic Review.
Chinese Language Podcast: Biotech Hot Topics Chat 202208
August 16, 2022 07:33 - 25 minutes - 11.1 MBBrian Yang and Dexter Yan discuss hot topics in China's biopharma industry in July 2022 in this new Chinese language podcast chat series.
Scrip’s Five Must-Know Things – 15 August 2022
August 15, 2022 03:44 - 14 minutes - 33.7 MBScrip’s Five Must-Know Things – 15 August 2022 by Citeline
Pink Sheet Podcast: Monkeypox Vaccine EUA, Drug Pricing Bill Fallout, US FDA’s IT Upgrade
August 12, 2022 17:54 - 49 minutes - 31.2 MBPink Sheet reporters and editor discuss the new monkeypox vaccine EUA, the potential impact of drug pricing legislation, and how things may have been different if the FDA already had a desired technology upgrade.
‘신약개발 없이 미래는 없다,’ 유한양행의 오픈이노베이션 전략
August 09, 2022 23:54 - 3 minutes - 8.38 MB유한양행이 글로벌 제약사로 성장하기 위해 선택한 오픈이노베이션 전략과 R&D 전략에 대해 유한양행의 중앙연구소장이신 오세웅 전무님을 인터뷰한 Scrip기사를 요약한 내용입니다. https://scrip.pharmaintelligence.informa.com/SC146768/No-Future-Without-New-Drugs-Yuhan-CSO-On-Open-Innovation-Strategy Korean-language podcast summarising a recent article from Scrip.
Digital Health Roundup: Cardio Smart Watches, Pear Therapeutics Own Reset, Agetech Boom
August 09, 2022 20:36 - 10 minutes - 6.09 MBIn this month’s Digital Health roundup, Medtech Insight’s Reed Miller talks about iRhythm and Withings’ smartwatches business, Barnaby Pickering reviews digital therapeutics Pear Therapeutics’ restructuring, and Marion Webb presents highlights from her new series on Agetech. Medtech Insight articles addressing topics discussed in this episode: Medtech Innovators Take on Fall Prevention, Mobility Challenges For Older Adults https://medtech.pharmaintelligence.informa.com/MT145689/Agetech-Inno...
Scrip’s Five Must-Know Things – 8 August 2022
August 08, 2022 02:56 - 16 minutes - 37.2 MBhttps://scrip.pharmaintelligence.informa.com/SC146845/Quick-Listen-Scrips-Five-MustKnow-Things
The ‘Dos and Don’ts’ Of EU Food Supplement Innovation, With Jenson R+’s Mihai Inceu
August 05, 2022 15:28 - 29 minutes - 68 MBIn this episode, HBW Insight talks to Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior Regulatory Affairs Officer at Jenson R+, Inceu highlights some of the issue companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to som...
The ‘Dos and Don’ts’ Of EU Food Supplement Innovation, With Jensen R+’s Mihai Inceu
August 05, 2022 15:28 - 29 minutes - 68 MBIn this episode, HBW Insight talks to Mihai Inceu about the challenges of innovating in Europe’s thriving food supplements market. Senior Regulatory Affairs Officer at Jensen R+, Inceu highlights some of the issue companies face in putting new wellness products onto the European market, particularly if they want to make health claims for herbal ingredients, also known as botanicals. As well as giving good advice about how to avoid getting into trouble with regulators, Inceu also points to som...
Medtech Monthly, Ep. 2: Where Does Diabetes Tech Stand?
August 03, 2022 16:03 - 25 minutes - 18 MBMedtech Monthly, Ep. 2: Where Does Diabetes Tech Stand? by Citeline
【3分で解説 世界のファーマ】第4回 コロナ治療薬ラゲブリオ アジアで人気の理由とは
August 02, 2022 23:34 - 3 minutes - 7.87 MB: 世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 A Japanese-language summary of selected content from Scrip and Pink Sheet, one story at a time. 今回取り上げた記事はこちら The article for this episode is: MSD’s Asia Pacific Chief On Lagevrio’s Gains In Clinical Utility Amid Paxlovid Luster （邦題意訳「アジアの医療現場で躍進 コロナ治療薬ラゲブリオの強みと戦略は」） https://scrip.pharmaintelligence.informa.com/SC146732/MSDs-Asia-Pacific-Chief-On-Lagevrios-Gains-In-Clinical-Utility-Amid-P...
Scrip’s Five Must-Know Things – 1 August 2022
August 01, 2022 02:23 - 13 minutes - 31.7 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC146801/Quick-Listen-Scrips-Five-MustKnow-Things
Pink Sheet Podcast: FDA User Fees, Real-Time Oncology Review, ALS Accelerated Approval, Opioid Suit
July 29, 2022 15:29 - 6 minutes - 4.06 MBPink Sheet reporter looks at the biggest US FDA and pharma industry stories of the week, including the status of US FDA user fee renewal legislation, new real-time oncology review program guidance, Biogen’s ALS accelerated approval play, and Teva settling opioid litigation.
Gennova CEO Singh On India’s mRNA Vaccine, Using Tech Against Cancer, Potential Equity Partnering
July 27, 2022 01:38 - 16 minutes - 12.6 MBGennova Biopharma’s founder CEO Sanjay Singh talks to Scrip on developing the first Indian and the world’s third mRNA vaccine against COVID-19, following Moderna and Pfizer. After a couple of years in the US at The National Institutes of Health, he returned to set up the company, which is looking at using the technology against cancer and infectious diseases like dengue and is now being sought by funds/companies for an equity stake https://scrip.pharmaintelligence.informa.com/SC146770/CEO-Of...
Global Self Care Trends With Johnson & Johnson’s Adam Ricciardone
July 25, 2022 21:02 - 19 minutes - 25.5 MBIn this episode, I speak to Adam Ricciardone, global head of self-care research and development at Johnson & Johnson Consumer Health. Adam identifies four macro trends the company is observing worldwide: total wellness, sustainability, a focus demographic shifts and the “techceleration” of self-care. International Self Care Day was last weekend on July 24, so Adam walks us through some of J&J’s new self-care technology and explains the importance of R&D in the self-care industry. Finally, whi...
Scrip’s Five Must-Know Things – 25 July 2022
July 25, 2022 01:32 - 16 minutes - 37 MBQuick Listen: Scrip's Five Must-Know Things https://scrip.pharmaintelligence.informa.com/SC146762/Quick-Listen-Scrips-Five-MustKnow-Things
Pink Sheet Podcast: Trial Diversity, More PTAB Issues, US FDA Controlled Substance Leader Elevated
July 22, 2022 16:07 - 19 minutes - 12.1 MBPink Sheet reporter and editors discuss another project to improve clinical trial diversity in the US, the Patent Trial and Appeal Board director review process, and the FDA promoting its head of controlled substance policy to deputy CDER director.
DCTs: The Future Of Remote Trials
July 22, 2022 12:50 - 32 minutes - 15.1 MBDCTs: Exploring The Innovative Technologies, Push For Diversity, Cybersecurity, And the Future Of Remote Trials While diversity is largely recommended by regulators today, it is quickly becoming apparent diversity is vital for successful clinical trials in the future. For sponsors to fulfil the requirements, continual exploration and use of decentralized trials (DCTs) are the obvious solutions. For more information, listen to the podcast with experts from our partner at Clario.
DCTS: The Future Of Remote Trials
July 22, 2022 12:50 - 32 minutes - 15.1 MBDCTS: Exploring The Innovative Technologies, Push For Diversity, Cybersecurity, And the Future Of Remote Trials While diversity is largely recommended by regulators today, it is quickly becoming apparent diversity is vital for successful clinical trials in the future. For sponsors to fulfil the requirements, continual exploration and use of decentralized trials (DCTs) are the obvious solutions. For more information, listen to the podcast with experts from our partner at Clario.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
July 21, 2022 15:35 - 22 minutes - 12.8 MBIn this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
급변하는 제약바이오 시장, 새로운 M&A 물결이 시작되었나?
July 20, 2022 23:53 - 4 minutes - 11.1 MB바이오텍 가치하락, 바이오신약의 특허 만료 등 시장상황의 변화로 글로벌 제약바이오 업계가 새로운 인수합병 파도에 휩쓸릴 수 있다는 Scrip Intelligence 기사를 요약한 내용입니다. https://scrip.pharmaintelligence.informa.com/SC146589/Are-Market-Conditions-Setting-Up-A-Biopharma-MA-Wave
Scrip’s Five Must-Know Things – 18 July 2022
July 19, 2022 02:04 - 15 minutes - 36.4 MBScrip’s Five Must-Know Things – 18 July 2022 by Citeline
Citeline Podcast Special: The Shifting Landscape For Drugs And Devices Post-Roe v. Wade
July 15, 2022 21:14 - 25 minutes - 14.2 MBArticles mentioned in this podcast: US FDA Has 10 Months To Provide Answer On Perrigo/HRA OTC Oral Contraceptive Application Allowing States To Ban Abortion Services Increases Calls For Making Birth Control Available OTC OTC Switch For Daily Oral Contraceptive Brandished In Senate Health Care Policy Duel Barriers To US OTC Emergency Contraceptive Sales Remain Despite Court Rebuke Of Restrictions Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process And For Consumer...
Pink Sheet Podcast: Novavax Gets EUA, Califf Sets US FDA Departure, Hemophilia Patients Want REMS
July 15, 2022 16:19 - 37 minutes - 23.4 MBPink Sheet reporters and editors discuss the FDA’s latest COVID-19 vaccine emergency use authorization, activities during the FDA commissioner’s remaining time in office, and patients requesting a gene therapy risk management plan.
Digital Health Roundup: Solutions For Heart, Loneliness; Diabetes Talks; Post-Roe Legal Advice
July 11, 2022 21:22 - 17 minutes - 9.75 MBIn this month’s Digital Health roundup, Medtech Insight’s Barnaby Pickering discusses DeHealth, which developed a platform built on cryptocurrency, and executive interviews with Glooko and Omada Health about their diabetes platforms. Marion Webb will highlight a conversation with Nixon Gwilt Law attorney Bethany Corbin about key steps developers of period-tracking apps can take to ensure that sensitive health data remains safe and private. Reed Miller discusses Braidio’s health information pl...
Pink Sheet Podcast: New Drug Pricing Bill, Second Amylyx US FDA Adcom, Skipping A Makena Vote
July 08, 2022 17:20 - 24 minutes - 14.8 MBPink Sheet reporters and editors discuss new changes to the Senate drug pricing bill, the FDA’s decision to call a second advisory committee meeting for Amylyx’s ALS drug, and Covis’ request to skip a vote during the hearing on Makena’s withdrawal.
Citeline中国生物制药热门话题聊
July 08, 2022 00:34 - 18 minutes - 10.1 MB欢迎来Citeline中国生物制药热点博客做客！ 分析热点，政策解读和行业热门追踪是我们的宗旨。 在首期的节目中，中国主编杨宏新Brian和资深记者严洁Dexter首先讨论了康方生物最新获得药监局批准，世界首个双特异抗体卡度尼丁单抗Cadonilimab，治疗宫颈癌（https://scrip.pharmaintelligence.informa.com/SC146649/China-Approves-Worlds-First-Bispecific-IO-Drug-Amid-PD-1L1-Glut）。 这个获批也是中国第一个批准治疗宫颈癌的肿瘤免疫治疗。默克的K药比较，这个获批有什么意义？对于其他在研的双特异抗体PD-1来说有什么影响？ 接下来的话题是最近国家药监局公布《关于进一步加强外资企业服务工作的通知》，其中特别提出要加快临床急需境外新药，罕见病，儿童用药和重大传染病新药的审评审批 （https://pink.pharmaintelligence.informa.com/PS146428/Invitation-Extended-New-Chinese-Policies...
Podcast: BD’s Polen Pursues ‘True North’ Path To High-Value Growth
July 06, 2022 21:03 - 26 minutes - 24.4 MBPodcast: BD’s Polen Pursues ‘True North’ Path To High-Value Growth by Citeline
3分で解説 世界のファーマ 第3回 国際進出を強める韓国企業たち
July 06, 2022 00:07 - 3 minutes - 7.72 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら: China Rush Over? Korean Firms Step Up To Seize Opportunities （邦題意訳「中国企業ブームに続くか？国際進出を強める韓国企業たち」） https://scrip.pharmaintelligence.informa.com/SC146600/China-Rush-Over-Korean-Firms-Step-Up-To-Seize-Opportunities 【コンサルティングサービスのご紹介】 ファーマインテリジェンスのコンサルティングチームは、製薬やバイオ技術、医療機器といった分野で活躍する企業のお客様と緊密に連携し、個別の課題をピンポイントで解決します。開発途中の薬剤に関するビジネス機会評価や売上予測、価格予測をはじめ、医療経済評価モデルや臨床試験計画、ベンチマークの策定...
Scrip’s Five Must-Know Things – 4 July 2022
July 04, 2022 03:11 - 14 minutes - 33.3 MBScrip’s Five Must-Know Things – 4 July 2022 by Citeline
It’s Coming Home: ImmunoACT Advances Plans For Cut-Price CAR-T In India
June 30, 2022 00:20 - 32 minutes - 18.7 MBImmunoACT CEO Dr Rahul Purwar outlines progress made by the firm’s early-stage CAR-T therapy in India, which he believes can be available at a tenth of the price of current on-market treatments or around the cost range for bone marrow transplant. Laurus Labs, which holds about 27% in ImmunoACT, is expected to help shape the firm’s globalization plans. https://scrip.pharmaintelligence.informa.com/SC146616/Whats-Next-At-Dr-Reddys-Biologics-CDMO-Cell-And-Gene-Therapy-Push https://scrip.pharmain...